QurAlis
1 follower
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causi... Read more
Org chart
Kasper Roet
Founder, CEO
Kasper Roet
Collapse
Vikas Sharma
Chief Business Officer
Chris Thomajan
Chief Financial Officer
Daniel Elbaum
Chief Scientific Officer
Hagen Cramer
Chief Technology Officer
Shirley Lasch
Head, Business Operations
Sudhir Agrawal
Senior Adviser
Barry F.
Vice President, Quality Assurance (glp/gcp)
Abi Foster
Executive Assistant And Business Operations Associate
Kevin Eggan
Founder
Emma Bowden
Senior Vice President, Head Of Clinical Development
